AAPL310.66-2.00 (-0.64%) ▼|ABBV254.65-0.11 (-0.04%) ▼|ABT95.84+0.21 (+0.22%) ▲|ACN142.14+5.18 (+3.78%) ▲|ADBE221.54+3.47 (+1.59%) ▲|AMAT554.50-38.29 (-6.46%) ▼|AMD516.11-35.94 (-6.51%) ▼|AMGN368.10+1.66 (+0.45%) ▲|AMT165.25+3.14 (+1.94%) ▲|AMZN245.98+1.82 (+0.75%) ▲|AVGO370.78-3.12 (-0.83%) ▼|AXP349.58-6.45 (-1.81%) ▼|BA231.68-2.86 (-1.22%) ▼|BAC59.86-0.04 (-0.07%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.43-1.78 (-0.18%) ▼|BMY57.97+1.27 (+2.24%) ▲|BNY152.91+2.95 (+1.97%) ▲|BRK-B504.00-2.58 (-0.51%) ▼|C140.77-3.09 (-2.15%) ▼|CAT940.12-29.80 (-3.07%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.89-3.61 (-1.75%) ▼|COP108.44+4.86 (+4.69%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.52+3.87 (+2.34%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX174.01+5.91 (+3.52%) ▲|DE603.61-31.63 (-4.98%) ▼|DHR194.19+0.57 (+0.29%) ▲|DIS97.48+0.07 (+0.07%) ▲|DUK128.22+2.25 (+1.79%) ▲|EMR137.91-3.65 (-2.58%) ▼|FDX312.88+2.95 (+0.95%) ▲|GD374.64-2.24 (-0.59%) ▼|GE366.98-11.70 (-3.09%) ▼|GEV1,077.08-74.96 (-6.51%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.03-1.82 (-2.34%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,042.98-12.31 (-1.17%) ▼|HD345.21-5.44 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.13+6.61 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.24+7.91 (+3.05%) ▲|JPM339.22+1.50 (+0.44%) ▲|KO84.05+1.09 (+1.31%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.56+35.50 (+2.96%) ▲|LMT535.38-2.62 (-0.49%) ▼|LOW220.90-2.88 (-1.29%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.62-1.48 (-0.28%) ▼|MCD282.21+2.71 (+0.97%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.83+0.77 (+0.93%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.01-1.14 (-0.72%) ▼|MO72.96+1.08 (+1.50%) ▲|MRK128.86+2.08 (+1.64%) ▲|MS222.04-0.06 (-0.03%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.47+1.03 (+1.18%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.21-0.13 (-0.30%) ▼|NOW110.73+2.80 (+2.59%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.60-2.16 (-1.50%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.75+3.44 (+2.30%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.79+3.03 (+1.64%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.85-0.52 (-0.26%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.93+1.31 (+1.30%) ▲|SO97.29+1.30 (+1.35%) ▲|SPG227.19+2.19 (+0.97%) ▲|T21.09+0.51 (+2.48%) ▲|TMO516.62-0.98 (-0.19%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.19+10.20 (+2.44%) ▲|UNP283.12+0.53 (+0.19%) ▲|UPS111.96+1.94 (+1.76%) ▲|USB62.89+0.06 (+0.10%) ▲|V352.20-5.05 (-1.41%) ▼|VZ42.59+0.52 (+1.24%) ▲|WFC87.18-0.27 (-0.31%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.69+5.25 (+3.85%) ▲|AAPL310.66-2.00 (-0.64%) ▼|ABBV254.65-0.11 (-0.04%) ▼|ABT95.84+0.21 (+0.22%) ▲|ACN142.14+5.18 (+3.78%) ▲|ADBE221.54+3.47 (+1.59%) ▲|AMAT554.50-38.29 (-6.46%) ▼|AMD516.11-35.94 (-6.51%) ▼|AMGN368.10+1.66 (+0.45%) ▲|AMT165.25+3.14 (+1.94%) ▲|AMZN245.98+1.82 (+0.75%) ▲|AVGO370.78-3.12 (-0.83%) ▼|AXP349.58-6.45 (-1.81%) ▼|BA231.68-2.86 (-1.22%) ▼|BAC59.86-0.04 (-0.07%) ▼|BKNG181.95+0.92 (+0.51%) ▲|BLK1,009.43-1.78 (-0.18%) ▼|BMY57.97+1.27 (+2.24%) ▲|BNY152.91+2.95 (+1.97%) ▲|BRK-B504.00-2.58 (-0.51%) ▼|C140.77-3.09 (-2.15%) ▼|CAT940.12-29.80 (-3.07%) ▼|CL95.03+1.64 (+1.76%) ▲|CMCSA23.41+0.03 (+0.13%) ▲|COF202.89-3.61 (-1.75%) ▼|COP108.44+4.86 (+4.69%) ▲|COST947.50-2.75 (-0.29%) ▼|CRM169.52+3.87 (+2.34%) ▲|CSCO111.79-2.19 (-1.92%) ▼|CVS104.33+2.25 (+2.20%) ▲|CVX174.01+5.91 (+3.52%) ▲|DE603.61-31.63 (-4.98%) ▼|DHR194.19+0.57 (+0.29%) ▲|DIS97.48+0.07 (+0.07%) ▲|DUK128.22+2.25 (+1.79%) ▲|EMR137.91-3.65 (-2.58%) ▼|FDX312.88+2.95 (+0.95%) ▲|GD374.64-2.24 (-0.59%) ▼|GE366.98-11.70 (-3.09%) ▼|GEV1,077.08-74.96 (-6.51%) ▼|GILD136.36+6.75 (+5.21%) ▲|GM76.03-1.82 (-2.34%) ▼|GOOG363.62-1.28 (-0.35%) ▼|GOOGL367.03+0.57 (+0.16%) ▲|GS1,042.98-12.31 (-1.17%) ▼|HD345.21-5.44 (-1.55%) ▼|HON225.05-6.13 (-2.65%) ▼|IBM306.13+6.61 (+2.21%) ▲|INTC110.39-11.81 (-9.66%) ▼|INTU281.17+9.03 (+3.32%) ▲|ISRG427.30-5.53 (-1.28%) ▼|JNJ267.24+7.91 (+3.05%) ▲|JPM339.22+1.50 (+0.44%) ▲|KO84.05+1.09 (+1.31%) ▲|LIN538.23-2.29 (-0.42%) ▼|LLY1,235.56+35.50 (+2.96%) ▲|LMT535.38-2.62 (-0.49%) ▼|LOW220.90-2.88 (-1.29%) ▼|LRCX326.13-24.07 (-6.87%) ▼|MA531.62-1.48 (-0.28%) ▼|MCD282.21+2.71 (+0.97%) ▲|MDLZ60.22+1.05 (+1.77%) ▲|MDT83.83+0.77 (+0.93%) ▲|META615.58+15.29 (+2.55%) ▲|MMM158.01-1.14 (-0.72%) ▼|MO72.96+1.08 (+1.50%) ▲|MRK128.86+2.08 (+1.64%) ▲|MS222.04-0.06 (-0.03%) ▼|MSFT388.84+2.10 (+0.54%) ▲|MU938.38-46.37 (-4.71%) ▼|NEE88.47+1.03 (+1.18%) ▲|NFLX76.18+0.16 (+0.21%) ▲|NKE43.21-0.13 (-0.30%) ▼|NOW110.73+2.80 (+2.59%) ▲|NVDA196.93+1.38 (+0.71%) ▲|ORCL141.60-2.16 (-1.50%) ▼|PEP144.98+1.69 (+1.18%) ▲|PFE24.07+0.35 (+1.48%) ▲|PG152.75+3.44 (+2.30%) ▲|PLTR134.37+1.83 (+1.38%) ▲|PM187.79+3.03 (+1.64%) ▲|QCOM182.97-3.51 (-1.88%) ▼|RTX200.85-0.52 (-0.26%) ▼|SBUX103.61+1.50 (+1.47%) ▲|SCHW101.93+1.31 (+1.30%) ▲|SO97.29+1.30 (+1.35%) ▲|SPG227.19+2.19 (+0.97%) ▲|T21.09+0.51 (+2.48%) ▲|TMO516.62-0.98 (-0.19%) ▼|TMUS184.73+2.94 (+1.62%) ▲|TSLA402.90-16.87 (-4.02%) ▼|TXN293.30-10.20 (-3.36%) ▼|UBER74.33+1.91 (+2.64%) ▲|UNH428.19+10.20 (+2.44%) ▲|UNP283.12+0.53 (+0.19%) ▲|UPS111.96+1.94 (+1.76%) ▲|USB62.89+0.06 (+0.10%) ▲|V352.20-5.05 (-1.41%) ▼|VZ42.59+0.52 (+1.24%) ▲|WFC87.18-0.27 (-0.31%) ▼|WMT111.54+0.89 (+0.80%) ▲|XOM141.69+5.25 (+3.85%) ▲|

19.8 C

New York

Wednesday, July 8, 2026

Tineco’s World #1 Floor Cleaner Range Up To 46% Off For Amazon Prime Day

Woven Woven Redefines Children’s Sleep Wellness with Innovative Bead-Free Weighted Blankets

Focusing on On-Chain-Native Prediction Markets: BM Wallet Launches Prediction Markets, Reimagining the Web3 User Experience

Tag: program

Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who purchased or otherwise acquired 3D Systems Corporation (3D Systems or the Company) (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the Class Period).

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

Oral formulation demonstrates comparable cardiovascular benefits to injectable GLP-1s CHICAGO, June 22, 2025 /PRNewswire/ -- A recent study found that oral semaglutide offers meaningful cardiovascular benefits...

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated...

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Results from the fixed-dose QWINT-1 study, along with the QWINT-3 and QWINT-4 studies, reinforce efsitora's potential to simplify insulin management with weekly dosing Lilly plans...

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

Once-weekly insulin helped patients achieve an average A1C of 6.92% in QWINT-1 trial Results support once-weekly insulin as effective alternative to daily treatment CHICAGO, June 22,...

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

Findings Highlight Potential for Novel Approach to Insulin Delivery in Pediatric Population CHICAGO, June 22, 2025 /PRNewswire/ -- Today, a new study demonstrates inhaled insulin...

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Red Cat Holdings, Inc. (RCAT) Investors with Substantial Losses Have Opportunity to Lead Investor...

SAN DIEGO, June 22, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, 2025, inclusive (the “Class Period”), have until Tuesday, July 22, 2025 to seek appointment as lead plaintiff of the Red Cat class action lawsuit. Captioned Olsen v. Red Cat Holdings, Inc., No. 25-cv-05427 (D.N.J.), the Red Cat class action lawsuit charges Red Cat as well as certain of Red Cat’s top current and former executives with violations of the Securities Exchange Act of 1934.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of 3D Systems Corporation ("3D Systems" or the...

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

Data presented simultaneously at the American Diabetes Association's® 85th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsProgram

Tineco’s World #1 Floor Cleaner Range Up To 46% Off For Amazon Prime Day

Woven Woven Redefines Children’s Sleep Wellness with Innovative Bead-Free Weighted Blankets

Focusing on On-Chain-Native Prediction Markets: BM Wallet Launches Prediction Markets, Reimagining the Web3 User Experience

Tag: program

Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein

Oral Semaglutide Significantly Improves Cardiovascular Outcomes in Individuals with Type 2 Diabetes

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the...

Lilly’s once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials

Once-Weekly Insulin Efsitora Achieves Comparable A1C Reduction to Daily Insulin Therapy

Inhaled Insulin Shown as a Safe and Effective Replacement for Standard-of-Care in Children with Type 1 Diabetes

INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Red Cat Holdings, Inc. (RCAT) Investors with Substantial Losses Have Opportunity to Lead Investor...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation – DDD

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

CagriSema Demonstrates Significant Weight Loss in Adults with Obesity

A. Fagundes Plumbing & Heating Inc. Celebrates National HVAC Tech Day by Investing in the Next Generation of Technicians

A. Fagundes Plumbing & Heating Inc. Celebrates National HVAC Tech Day by Investing in the Next Generation of Technicians

AI Integration Accelerates Mathematical Discovery Algorithms: Analyzing Computational Efficiency Gains

The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us